Evofem Biosciences Inc (NASDAQ:EVFM) Stock Rebounds Sharply After The Fall

January 20, 2022

A stock that is quite likely to be in focus among investors this morning is that of Evofem Biosciences Inc (NASDAQ:EVFM). It had emerged as one of the major gainers on Wednesday and had managed to clock gains of as much as 22% for the day amidst significant interest. Trading Data On Wednesday, EVFM stock soared 22.86% to $0.4875 with 12.99 million shares, compared to its average volume of 4.26…

Read More >>

Evofem Biosciences Inc (NASDAQ:EVFM) Stock Extends Rally: Jumps 21% in a Week

September 1, 2021

Although there has been no news about Evofem Biosciences Inc (NASDAQ:EVFM) for more than two weeks, the company’s stock has made a strong move over the course of the past week or so and the move continued on Tuesday. The stock was in considerable focus yesterday as it ended the day with gains of 13% and thereby took its gains over the course of the past week to as much…

Read More >>

Evofem Biosciences Inc (NASDAQ:EVFM) Stock Gains 5% in a Week

August 24, 2021

Over the course of the past week, investors have flocked to the Evofem Biosciences Inc (NASDAQ:EVFM) stock and hence, it is no surprise that the stock managed to clock gains of 5% during the period. While the gains may be quite notable, it is also necessary to keep in mind at the same time that there has been no news about the company at all during the past week. In…

Read More >>

Evofem Biosciences Inc (NASDAQ:EVFM) Stock Continues to Fall: Down 12% in a Week

August 16, 2021

This past week, the Evofem Biosciences Inc (NASDAQ:EVFM) stock was in the middle of a strong selloff and ended the week with a decline of 12%. On Friday alone, the stock recorded a decline of 7%. It should be noted that last week the company had announced its financial results for the quarter and the six month period, both of which ended on June 30, 2021. The Chief Executive Officer…

Read More >>

Evofem Biosciences Inc. (NASDAQ:EVFM) Stock Suddenly Jumps: Should You Buy?

August 10, 2021

Shares of Evofem Biosciences Inc. (NASDAQ:EVFM) jumped 5%. Recently the company offered interim data at Phexxi for Q2 2021 and provided new insights regarding women using hormone-free contraceptives. In Q2 2021, over 14,000 Phexxi units were dispensed, with around 5,400 healthcare providers prescribing Phexxi. Since the launch of Phexxi, more than 7,00 providers in healthcare have prescribed Phexxi. Most importantly, around 60% of new users of the contraceptive method range…

Read More >>